Menu
GWAS Study

Trans-ethnic genome-wide association study of severe COVID-19.

Wu P, Ding L, Li X et al.

34465887 PubMed ID
GWAS Study Type
203 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WP
Wu P
DL
Ding L
LX
Li X
LS
Liu S
CF
Cheng F
HQ
He Q
XM
Xiao M
WP
Wu P
HH
Hou H
JM
Jiang M
LP
Long P
WH
Wang H
LL
Liu L
QM
Qu M
SX
Shi X
JQ
Jiang Q
MT
Mo T
DW
Ding W
FY
Fu Y
HS
Han S
HX
Huo X
ZY
Zeng Y
ZY
Zhou Y
ZQ
Zhang Q
KJ
Ke J
XX
Xu X
NW
Ni W
SZ
Shao Z
WJ
Wang J
LP
Liu P
LZ
Li Z
JY
Jin Y
ZF
Zheng F
WF
Wang F
LL
Liu L
LW
Li W
LK
Liu K
PR
Peng R
XX
Xu X
LY
Lin Y
GH
Gao H
SL
Shi L
GZ
Geng Z
MX
Mu X
YY
Yan Y
WK
Wang K
WD
Wu D
HX
Hao X
CS
Cheng S
QG
Qiu G
GH
Guo H
LK
Li K
CG
Chen G
SZ
Sun Z
LX
Lin X
JX
Jin X
WF
Wang F
SC
Sun C
WC
Wang C
Chapter II

Abstract

Summary of the research findings

COVID-19 has caused numerous infections with diverse clinical symptoms. To identify human genetic variants contributing to the clinical development of COVID-19, we genotyped 1457 (598/859 with severe/mild symptoms) and sequenced 1141 (severe/mild: 474/667) patients of Chinese ancestry. We further incorporated 1401 genotyped and 948 sequenced ancestry-matched population controls, and tested genome-wide association on 1072 severe cases versus 3875 mild or population controls, followed by trans-ethnic meta-analysis with summary statistics of 3199 hospitalized cases and 897,488 population controls from the COVID-19 Host Genetics Initiative. We identified three significant signals outside the well-established 3p21.31 locus: an intronic variant in FOXP4-AS1 (rs1853837, odds ratio OR = 1.28, P = 2.51 × 10-10, allele frequencies in Chinese/European AF = 0.345/0.105), a frameshift insertion in ABO (rs8176719, OR = 1.19, P = 8.98 × 10-9, AF = 0.422/0.395) and a Chinese-specific intronic variant in MEF2B (rs74490654, OR = 8.73, P = 1.22 × 10-8, AF = 0.004/0). These findings highlight an important role of the adaptive immunity and the ABO blood-group system in protection from developing severe COVID-19.

65 Chinese ancestry cases, 138 Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

203
Total Participants
GWAS
Study Type
No
Replicated
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.